| n | OR | Std. Err. | P-value | IC à 95% |
Age (years) |
|
|
|
|
|
<50 | 64 | 2.71428 | 2.58536 | 0.294 | [0.42 - 17.55] |
[50 - 75[ | 239 | 3.85073 | 3.55870 | 0.145 | [0.63 - 23.56] |
≥75 | 17 | 4.87499 | 5.25110 | 0.141 | [0.59 - 40.26] |
Male sex | 178 | 1.70679 | 0.43080 | 0.03 | [1.05 - 2.77] |
Socio-economical level |
|
|
|
|
|
High | 26 | 0.38541 | 0.16831 | 0.029 | [0.16 - 0.91] |
Middle | 145 | 0.71098 | 0.18512 | 0.19 | [0.43 - 1.18] |
Comorbidities |
|
|
|
|
|
Hypertension | 270 | 7.28073 | 2.44842 | <0.001 | [3.77 - 14.07] |
Dyslipidemia | 73 | 1.85229 | 0.59272 | 0.054 | [0.99 - 3.47] |
Duration > 5 yrs | 185 | 1.00788 | 0.00166 | <0.001 | [1.04 - 1.10] |
HbA1c > 7% | 259 | 0.89600 | 0.28337 | 0.730 | [1.48 - 4.53] |
Complications |
|
|
|
|
|
Microangiopathy | 265 | 7.33 | 2.37329 | <0.001 | [3.89 - 13.89] |
Macroangiopathy | 63 | 1.80 | 0.6107 | 0.082 | [0.92 - 3.50] |
None | 46 | 0.156 | 0.06612 | <0.001 | [1.48 - 4.53] |
Treatment |
|
|
|
|
|
OAD | 199 | 0.35 | 0.09978 | <0.001 | [0.20 - 0.61] |
Insulin | 115 | 1.22992 | 0.31807 | 0.424 | [0.74 - 2.04] |
BSRA | 203 | 0.82512 | 0.72634 | <0.001 | [0.71 - 0.90] |
Ica | 141 | 0.97475 | 0.50605 | 0.008 | [0.19 - 0.98] |
Diuretics | 61 | 0.37057 | 0.44726 | 0.34 | [0.72 - 2.60] |